Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print

Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Nature may help those suffering from chronic back pain, shows study
- UN says AIDS still killing one person every minute
- WHO alerts flavoured nicotine products driving youth addiction
- UN study reveals alcohol consumption is linked to higher risk of pancreatic cancer
- Even few nights of insufficient sleep can affect heart problems, reveals study